Comments
Shares of Ranbaxy Laboratories will stop trading on the BSE and the NSE from April 6 as it is getting merged with Sun Pharmaceutical Industries. For every share, shareholders of Ranbaxy will get 0.8 share of Sun Pharma. With April 1 being the last day, both the stocks may see higher activity. April 7 has been fixed as the record date to find eligible shareholders to get Sun Pharma shares. All F&O contracts on Ranbaxy will also expire on April 1.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.